Stock comparison

JNJvsXOM

Johnson & Johnson vs Exxon Mobil Corp. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

JNJ

Johnson & Johnson

$234.18

+16.15%

Pharmaceuticals$585.7BNYSE

XOM

Exxon Mobil Corp

$146.44

+22.50%

Energy$650.5BNYSE

60-day price, rebased to 100

JNJ +7.18% · XOM +8.60%

Round-by-round

JNJ 2·XOM 3· 1 tie

EdgeXOM

Valuation upside

-49.50% vs -13.40% to DCF fair value

EdgeJNJ

Balance-sheet strength

Altman Z 5.48 vs 4.88

EdgeJNJ

Fundamental quality

Piotroski 4.00 vs 3.00 (of 9)

EdgeXOM

Growth + margins

Rule-of-40 -5.70 vs -3.10

EdgeXOM

60-day momentum

+7.18% vs +8.60% price return

Tie

Market-cap liquidity

$585.7B vs $650.5B

Verdict

Across 6 categories, XOM takes the edge with 3 wins to 2 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy on JNJ or XOM

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.